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Feline Symposium
Feline Vaccinations
There’s that famous saying, “An ounce of
prevention…” However, where vaccines are
concerned, prevention can come at a price. Dr.
Margret Casal, assistant professor of medical
genetics at the School, highlighted the many
variables one must consider in tailoring a vac-
cine protocol to a particular cat, and explained
the rationale behind VHUP’s feline vaccine
protocol.
“Each cat’s vaccine schedule should be
based on its lifestyle, breed and environment,”
said Dr. Casal.
It should also take into account the
risk:reward ratio for giving a certain vaccine to
an individual cat. The negative sequela to vac-
cination include tissue reaction at the injection
site; anaphylaxis, which occurs more common-
ly in dogs than cats; delayed allergic response;
introduction of disease (more common with
intranasal vaccine); and problems associated
with vaccine contamination.
In order to minimize these risks, several
decisions must be made regarding vaccination
strategy. These include type of vaccine (killed
vs. attenuated), route of administration –
which should most closely mimic the natural
route of infection, and frequency of revaccina-
tion. The patient’s immune status should also
be taken into consideration.
Modified-live vaccines, which may be
intranasal or injectable, have the advantage of
evoking a rapid immune response. Unlike
some injectable vaccines, intranasal modified-
live vaccines are not associated with sarcomas.
However, they can cause mild clinical signs of
disease, as well as a carrier state with possible
viral shedding. Modified-live vaccines should
never be used in pregnant queens because of
potential harm to the fetus.
Killed vaccines, while posing no risk for
viral shedding, require adjuvants to effectively
stimulate the host’s immune system. These
adjuvants have been implicated in the forma-
tion of vaccine-associated sarcomas. Further,
killed vaccines must be boostered.
Frequency of revaccination is a subject with
many opinions. It is difficult to determine one’s
true immunity to an agent by simply measur-
ing antibodies. And cell-mediated immunity, a
more targeted response that some agents stim-
ulate, is difficult to measure. While absolute
immunity is hard to gauge, annual boosters are
probably overkill, said Dr. Casal, because
“you’ve already trained the body and the
immune system to remember certain virus
components.”
Feline calicivirus, which is highly conta-
gious, can cause chronic ulcerative stomatitis
with persistent infection. Febrile limping syn-
drome, a reaction sometimes associated with
attenuated calicivirus vaccination, is character-
ized by shifting lameness and fever. VHUP’s
vaccine protocol for calicivirus, which is usually
combined with feline viral rhinotracheitis and
feline panleukopenia, is a kitten series of shots
given every 3-4 weeks from 6-8 weeks to 12-16
weeks of age, a first adult booster given at 15
months, and a booster every three years
thereafter.
Rabies is more likely to be transmitted by
cats than dogs. Although Pennsylvania law
states that rabies vaccination is mandatory only
for cats that spend any time indoors, Dr. Casal
recommended also vaccinating outdoor pets,
such as barn cats. The traditional killed-virus
vaccine must be boostered one year after the
initial vaccine and every three years thereafter.
The killed rabies vaccine has been implicated
in causing sarcomas. Recently available is a
recombinant-virus vaccine that has no poten-
tially-dangerous adjuvants. In the absence of
any long-term studies on the efficacy of this
new vaccine, Dr. Casal recommended booster-
ing it annually.
The feline leukemia virus (FeLV) vaccine is
not completely effective, and can cause poten-
tially severe adverse reactions. Therefore, it is
only recommended for cats that go outdoors.
To avoid maternal antibodies, the vaccine
should not be given before 10 weeks of age,
and must be boostered annually. Dr. Casal cau-
tioned that there is no advantage to vaccinating
FeLV+ cats. On the horizon are DNA vaccines
against FeLV that have longer immunity dura-
tion and no reported side effects.
Dr. Casal discouraged vaccinating cats
against Chlamydophila, feline infectious peri-
tonitis (FIP) and bordetella. She cited the low
disease prevalence of Chlamydophila and the
high frequency of adverse reactions to the vac-
cine. Because of their questionable efficacy, she
added, the FIP and bordetella vaccines should
not be routinely administered.
Feline immunodeficiency virus (FIV) vac-
cines, though not yet commercially available,
are currently in development. The most prom-
ising of these are the inactivated dual-subtype
and the fixed-infected-cell vaccines.
Feline Respiratory Disease
The feline mystique can be breathtaking for
cat fanciers. Likewise, many medical conditions
can be breathtaking literally for cats. Dr. Reid
Groman, lecturer in emergency and critical
care medicine at the School, presented the
manifold causes of feline respiratory disorders.
Cats are subject to a variety of upper and
lower respiratory tract problems. These include
infection, nasal foreign body/polyp/malignan-
cy, allergic airway disease, pleural space disease
and congestive heart disease. Other afflictions,
like stress, pain and anemia, can mimic pri-
mary respiratory disease by causing increased
respiratory rate or tachypnea.
The most common upper respiratory disor-
der in cats is chronic nasal discharge secondary
to infection. “We see cats all the time presented
with chronic upper respiratory infections
(URIs),” Dr. Groman said. “These chronic snuf-
fling cats are among the most frustrating cases
to treat.”
Often medically incurable – though tem-
porarily manageable – these cats are usually
afflicted with a virus. The most common of
these viruses is feline herpesvirus (FHV-1),
which causes feline viral rhinotracheitis. Signs
include sneezing, coughing, excess salivation
and ocular discharge. Although infection usu-
ally resolves in a few weeks with supportive
care, feline viral rhinotracheitis can lead to sec-
ondary bacterial infection and damage to the
bones of the nares and sinuses. Extremely con-
tagious, feline calicivirus is associated with
milder respiratory signs and tissue ulceration.
Both herpes- and calicivirus are ubiquitous
in the general cat population, have an even
higher prevalence in colonies, may remain
latent in the host, and can be shed when the
host is under stress.
Common bacterial causes of nasal discharge
are Pseudomonas, Pasteurella, Staphylococcus
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and Actinobacillus. All normal inhabitants of
the nasal/sinus mucosa, these bacteria do not
cause infection by themselves. Rather, they are
opportunistic agents that cause secondary
infection of tissues already inflamed by viruses.
Two primary bacterial causes of URIs are
Chlamydophila and Bordetella bronchiseptica.
Formerly called Chlamydia, Chlamydophila
causes often-recurrent mild respiratory com-
promise and conjunctivitis. B. bronchiseptica,
which causes kennel cough in dogs, is thought
to be a common primary disease agent in cats,
in whom signs include fever, nasal discharge
and coughing. Associated with overcrowding
and poor ventilation, B. bronchiseptica infec-
tion is easily treatable with antibiotics.
Feline nasal discharge can also result from
fungal infection (Cryptococcus, Aspergillus,
Blastomyces, Histoplasma), foreign bodies such
as grass awns lodged in the nasal mucosa,
malignancy (squamous cell carcinoma, lym-
phosarcoma, adenocarcinoma) and nasopha-
ryngeal polyps.
Nasopharyngeal polyps occur in the
eustachian tubes and present with sneezing,
difficulty eating, and other signs of middle ear
infection. Himalayans, Persians and Siamese
cats are predisposed to nasopharyngeal polyps.
Workup of feline nasal discharge includes a
thorough physical exam, complete blood
count, blood chemistry panel, urinalysis, feline
leukemia virus (FeLV)/feline immunodeficien-
cy virus (FIV) testing and head/chest x-rays.
CT scanning and/or endoscopy may be per-
formed if a nasal/sinus tumor or nasopharyn-
geal polyp is suspected, and endoscopy is done
to rule out a foreign body. If infection is sus-
pected, a nasal flush can be performed to
retrieve upper airway fluid for culture and
cytology.
Treatment of feline URIs is as varied as the
causes. Though symptomatic treatments like
antihistamines and topical decongestants have
questionable efficacy, said Dr. Groman, sup-
portive therapies like airway humidification,
appetite stimulants and flavorful foods are
important. For secondary bacterial infection,
Dr. Groman recommended pulsed, combina-
tion antibiotic therapy with agents like Orbax,
Doxycycline and Zithromax. Viral infections
are sometimes treated with antiviral drugs like
Zovirax, Herplex and interferon. Endoscopy
may be used to facilitate manual removal of
any foreign bodies. For removal of nasopha-
ryngeal polyps, a surgical procedure called
bulla osteotomy is recommended by many vet-
erinarians. Without this aggressive procedure,
which exposes the middle ear canal after
removing the polyp, up to one third of affected
cats experience polyp recurrence.
The most common lower respiratory tract
disease in cats is feline bronchial asthma. An
obstructive airway disease, it is marked by
increased responsiveness in the airways, airway
narrowing and mucus. “It is a reversible situa-
tion where animals have an exaggerated
response to something provocative in the envi-
ronment,” Dr. Groman explained.
Associated with culprits like food allergy,
dust, mold, smoke, and heartworm infection,
feline bronchial asthma generally presents with
sudden onset of labored breathing, chronic
cough, wheezing and increased respiratory rate.
Diagnostic tools include radiography, blood
work and fecal exam. Treatment may consist of
flow-by oxygen, bronchodilators and corticos-
teroids (injection and/or nebulization). “A
rewarding disease to treat,” said Dr. Groman,
“feline bronchial asthma requires long-term
therapy.”
New Cancer Treatments for Cats
Cats are prone to several types of neoplastic
conditions. Dr. Craig Clifford, resident in
oncology at VHUP, discussed the mechanisms
and treatment options for these cancers.
Cancer is an abnormal or unregulated cell
growth and can be benign or malignant.
Benign tumors are generally slow growing,
locally invasive and often curable with a single
form of therapy. Malignant neoplasia, on the
other hand, is characterized by rapid growth
and propensity to spread via the blood or lym-
phatic vessels. It requires combined therapy for
effective treatment. Cancer is a multi-step
process that results from cumulative damage to
genes. Causes include environmental carcino-
gens (chemical, physical, or radiological), hor-
mones, viruses and inflammation. Certain
breeds, such as Siamese, are predisposed to
developing cancer.
The common cancers in cats are lym-
phosarcoma (LSA), vaccine-associated sarcoma
(VAS), mammary gland tumor, squamous cell
carcinoma and mast cell tumor. The most
prevalent of these, LSA accounts for about one
third of all feline cancer cases. LSA involves
unregulated growth of lymphocytes. “One of
these cells turns and becomes bad, and spreads
to other parts of the body,” explained Dr. Clif-
ford. LSA most frequently affects one or more
of the following tissues: gastrointestinal tract,
lymph nodes, bone marrow, blood, medi-
astinum, nasal passages, kidney and brain.
Causes of LSA include genetic factors, inflam-
matory bowel disease (IBD), second-hand
smoke and feline leukemia virus (FeLV).
Although it most frequently affects middle-
aged-to-older cats, LSA has a bimodal age pre-
disposition, peaking in young – usually FeLV+
– cats, and in older – typically FeLV- – cats.
Recent studies show that up to 15 percent of
cats with LSA are FeLV+. The retrovirus inte-
grates itself into the genome of the cat, allow-
ing cells to proliferate abnormally and “throw-
ing the entire process off,” Dr. Clifford
explained.
Diagnostic tools for LSA include blood
work, urinalysis, radiographs, ultrasound,
endoscopy and the gold standard: biopsy or
cytology from fine needle aspirates. LSA treat-
ment may involve a combination of surgery,
chemotherapy and radiation. Surgery is gener-
ally limited to the excision of masses such as in
the gastrointestinal tract. Radiation therapy is
used to shrink focal masses, such as nasal LSA.
Chemotherapy involves a sequential, weekly
protocol that rotates a variety of agents. In peo-
ple, the goal of chemotherapy is cancer cure. In
animals, however, the goal is often palliation.
Therefore, lower drug dosages are used in ani-
mals than in people. Likewise, side effects,
which include anorexia, nausea and decreased
white blood cell count, are generally fewer.
These side effects are often preventable with
the use of appetite stimulants, antiemetics
(prevention of vomiting), antibiotics and fluid
therapy. In our experience, side effects occur in
less than ten percent of treated cats. LSA carries
a varied prognosis, with survival time ranging
from a few months (FeLV+ cat treated with
chemotherapy) to over a year.
VAS have increased in frequency at VHUP
by 61 percent from 1987 to 1991, occurring in
middle-aged-to-older cats, with no breed pre-
disposition. Associated with the rabies and
FeLV vaccines, these vaccination-site tumors
develop about 340 days after vaccination (11
[FeLV] 26 mos [rabies]). The risk increases
with multiple injections. These tumors, which
usually originate with post-vaccinal inflamma-
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tion at the vaccination site, may involve muta-
tions in tumor suppressor genes. VAS, which
can metastasize by the blood, should be sus-
pected if inflammatory tissue is still proliferat-
ing one month after vaccination, is greater than
2 cm. in size, and persists for over three
months after vaccination (“1-2-3 rule”).
Although VAS are definitively diagnosed by
biopsy, other diagnostic tools, like blood work,
FeLV testing, radiographs, CT scans and MRIs,
might be useful in further characterizing the
extent of the neoplastic process. VAS are treated
aggressively with surgery; however, tumor
recurrence is common. For appendicular
lesions, limb amputation carries the best prog-
nosis. Radiation therapy may be performed
either pre- or post-operatively, usually in 3-4-
week courses of daily therapy. These treatments
are often combined with chemotherapy.
Dr. Clifford urged owners to continue vac-
cinating their cats. “These tumors are not
uncommon but are not a reason to not vacci-
nate,” he said. Rather, owners should ensure
that the rabies vaccine is administered in the
right hind leg and FeLV in the left. Also, vac-
cines should not be given interscapularly.
Cancer cachexia progressive, involuntary
weight loss in the face of adequate nutrition, is
a problem in cats suffering from various can-
cers, particularly VAS, lymphosarcoma,
leukemia, and mammary gland tumors, but
can occur with any cancer. This common con-
dition is associated with decreased response to
therapy, impaired immunity and poor quality
of life. Cats suffering from cancer cachexia
should be fed complex carbohydrates, high-
quality protein sources and increased fat
(omega-3 fatty acids).
Lastly, Dr. Clifford discussed many of the
clinical trials in VHUP’s oncology service and
the goal of these trials is “to provide a more
efficacious therapy for different cancers as well
as to improve the quality of life in our
patients.” Due to limitations in funding for vet-
erinary studies, Dr. Clifford encouraged owners
to become proactive in helping to fund feline
cancer studies.
Feline Urinary and Renal Problems
Working as the filtration unit for the blood,
the urinary system purges the body of meta-
bolic end products and maintains serum elec-
trolyte concentrations within narrow parame-
ters. If any part of this system malfunctions, the
consequences can be serious. Dr. Meryl
Littman, V’75, associate professor of medicine
at the School, summarized the problems that
commonly affect the feline upper and lower
urinary tracts.
When urinary pathology occurs, the first
step is to localize the problem to the upper
(kidneys) versus the lower (bladder/urethra)
urinary tract. Kidney disease usually presents
with vague, often subtle, systemic signs. These
include lethargy, decreased appetite, vomiting,
polyuria/polydipsia and possible hypertensive
damage, such as stroke and retinal
detachment. “When the kidneys are sick, the
whole body is sick,” Dr. Littman explained,
“because the kidneys are not getting rid of the
waste products from the bloodstream.”
On physical examination, abdominal palpa-
tion may reveal shrunken kidneys – possibly
due to chronic renal failure – or enlarged kid-
neys, with etiologies ranging from acute renal
failure to lymphosarcoma to feline infectious
peritonitis (FIP).
The main diagnostic values for kidney dis-
ease are blood urea nitrogen (BUN) and serum
creatinine, which become elevated with the loss
of 75-85% of renal function. Other diagnostic
tests include complete blood count (CBC),
serum chemistry panel, T4, urinalysis, urine
culture, blood pressure measurement, imaging
studies, testing for infectious agents such as
Toxoplasmosis and feline leukemia virus
(FeLV), and kidney aspirate +/- biopsy.
Renal failure is treated with rehydration,
correction of electrolyte imbalances, dietary
modification (reduced protein/phosphorus),
antihypertensives, erythropoietin (to correct
associated anemia), antiemetics, anti-ulcer
drugs, and medications such as antibiotics or
chemotherapy to address underlying
problems. For suitable candidates, renal trans-
plantation is also available.
Feline lower urinary tract disease (FLUTD)
– a constellation of disorders affecting urine
outflow via the bladder and the urethra – is
most commonly caused by cystitis, or inflam-
mation (usually sterile, in cats) of the
bladder. Other causes of FLUTD, in descending
order of frequency, include urethral blockage
(male cats), urinary tract stones (male and
female cats), bacterial cystitis and anatomic
defects.
Unlike kidney disease, FLUTD tends to
manifest overtly. Clinical signs include
increased frequency of urination, straining to
urinate, vocalizing, and expelling small
amounts of bloody urine. In urethral blockage,
vomiting, lethargy and death can also occur.
Physical exam helps to characterize the
cause of FLUTD. If cystitis, or bladder inflam-
mation, is present, the bladder is usually small
and may contain “sand” or calculi that can
sometimes be palpated. If the urethra is
blocked, however, the bladder will be enlarged
and tense.
Diagnostic tests for FLUTD include urinaly-
sis, urine culture, imaging studies, and rarely,
cystoscopy and/or surgery/biopsy. Stone analy-
sis may also be performed, pursuant to deter-
mining appropriate dietary modifications:
Dietary acidification can reduce and prevent
struvite sand or calculi, while alkalinizing
agents are effective against calcium oxalate sand
or calculi. In addition to special diets and
dietary pH modifiers, sterile cystitis can be
treated with amitriptyline, antispasmodics and
antiinflammatory medications.
Calculi or sandy plugs can cause complete
obstruction at the narrow part of the urethra.
A proteinaceous mix of mucus and sandy grit –
usually struvite or oxalate, the plug must be
dislodged via urethral catheterization. A clinical
emergency, urethral blockage must be treated
rapidly with intravenous fluids, antispasmodic
medications and sometimes eventually surgery
(penile urethrostomy) to excise the narrowed
portion of the urethra. Therapy may also
include antibiotics and dietary modification.
Bacterial cystitis, which is not very common
in cats, is diagnosed with urine culture/sensi-
tivity and treated with antibiotics. Anatomic
defects, such as urachal diverticulum, are
usually treated surgically.
Some of the clinical signs of intrinsic uri-
nary problems, such as urinating outside the
litter box, can also be caused by behavior prob-
lems. Once physical etiologies have been ruled
out, behavior problems can be addressed. Uri-
nating outside the litter box can be a normal,
though unacceptable, territorial marking
behavior. Neither punishment nor positive
reinforcement is effective in reducing
marking. However, Dr. Littman said, “You don’t
have to make these cats live outside or put
them to sleep.” Psychotropic medications such
as amitriptyline, buspirone and fluoxetine are
effective against this problem.
Cats may also urinate outside the litter box
because of surface or location preferences/aver-
sions. Dr. Littman recommended experiment-
ing with different types of litter (clumping vs.
regular vs. less dusty litter; unscented vs.
deodorized litter; sand, dirt, etc.), cleaning the
litter regularly, and using several litter boxes in
different locations.
Feline Arterial Thromboembolic Disease
Characteristically feline and exquisitely trag-
ic, feline arterial thromboembolic disease
(FATE) is the typical presentation of “stroke” in
cats. Dr. Annika Linde, resident in cardiology at
VHUP, discussed the underlying causes, patho-
genesis, clinical signs, diagnosis and treatment
of FATE.
Arterial emboli are not uncommon in cats,
said Dr. Linde. “Cats experience these throm-
boembolic events more frequently and more
easily than other species would,” she explained.
Cardiomyopathy either hypertrophic,
restrictive or dilated – is the chief cause of
FATE. In fact, said Dr. Linde, over 90 percent of
cats afflicted with FATE have underlying heart
muscle disease. Other etiologies include hyper-
coagulability, neoplasia, corticosteroid adminis-
tration and presence of a foreign body.
Cats are predisposed to clot formation
because their red blood cells are prone to
aggregation, their platelet volume:body mass
ratio is high, and their platelets have a propen-
sity to aggregate. This tendency is exaggerated
when endothelial damage is present or blood
flow is sluggish as a result of heart disease. In
cats afflicted with cardiomyopathy, the left atri-
um the cardiac delta to the systemic circulation
often enlarges. “If a thrombus formed in this
area dislodges,” she explained, “it can go direct-
ly out into the body and cause the syndrome
that we see.”
Most commonly, a “saddle thrombus” – a
clot lodged at the aortic trifurcation in the cau-
dal abdomen – forms. Alternatively, thrombi
may settle in the smaller channels, such as the
brachial, renal or femoral arteries. Clinical
signs depend on the location at which the
thrombus/thrombi lodge(s).
The typical FATE patient is a middle-aged-
to-older cat, although cats of any age can be
afflicted. FATE occurs in male cats with twice
the frequency as in females. Common clinical
signs include pain – often accompanied by
vocalization, and cold, blue, paralyzed limbs
(bilateral or unilateral; usually hind limbs).
Affected cats may also exhibit vomiting, diffi-
culty breathing and signs associated with renal
failure. Alternatively, sudden death may be the
only clinical sign, particularly if clots lodge in
the left heart, valvular channels or proximal
aorta. The other reason cats often do not pres-
ent until end-stage damage has occurred, said
Dr. Linde, is that “they are very good at hiding
symptoms.”
FATE is diagnosed by a combination of car-
diac evaluation, blood pressure measurement
and laboratory tests. Heart auscultation may
reveal tachycardia or – in late stages – bradycar-
dia, arrhythmias, and murmurs. Electrocardiog-
raphy (ECG) might show abnormal QRS com-
plexes. On thoracic radiographs, the heart
silhouette may appear atypical, the left atrium
may appear enlarged and fluid may be apparent
in the lungs as a result of secondary congestive
heart failure. Echocardiography often reveals
thickened heart walls and constricted chambers,
particularly since HCM is the most common
form of cardiomyopathy in the cat. However,
other cardiomyopathies can also be the underly-
ing etiology. Doppler analysis may show reduced
blood pressure in affected limbs. Renal values
and muscle enzymes may be elevated, indicat-
ing, kidney and muscle damage, respectively.
FATE is a clinical emergency that must be
treated aggressively. Therapy includes pain con-
trol, vasodilators and thrombolytic agents, such
as streptokinase, urokinase and tissue-plas-
minogen activator (t-PA). Underlying heart
disease also must be addressed, and additional
thrombus formation prevented by either
aspirin or coumadin.
Though treatment options are available,
many cases of FATE have bad outcomes. Of
144 total cases analyzed in two separate studies
between 1977 and 1998, approximately one
third of affected cats died and one third were
euthanized. The mean survival time in the
remaining 1/3 was about one year.
–Joan Capuzzi Giresi, C’86, V’98
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We need your help. Do you have time to
volunteer next Spring, February through June
(an average of one shift or more per week) and
don’t mind getting dirty or hard work? Do you
like horses and love foals? Are you curious
about what cutting edge veterinary medicine is
all about? Are you over 16? If so, come and join
our neonatal intensive care team as a foal sitter.
Working in the NICU is like nothing you
have ever done before. You will be working
with critically ill newborn foals (and occasion-
ally other newborns) that are being watched
over by their anxious and attentive dams. You
may be asked (after being instructed) to “sit”
with the foals, insuring that a variety of patient
lines (including intranasal oxygen lines, naso-
tracheal tubes, nasogastric feeding tubes, uri-
nary catheters, and intravenous catheters) are
not pulled out. Depending on the time of day
you choose to work you will help with a vari-
ety of diagnostic and therapeutic procedures,
which may include catheterization, radiogra-
phy, and ultrasonography. During late night
shifts you may be helping us while we work up
emergencies or watch us foal mares in our
high-risk pregnancy program. Of course, there
are more mundane chores as well, such as put-
ting a dent in a mountain of laundry, restock-
ing supplies or cleaning.
The work can be strenuous. There is a lot of
lifting and kneeling. You have to be willing to
get dirty – changing foal diapers, catching
urine, etc. If you are assigned a foal that is
hyperactive (as they can be as they recover
from mild brain damage) you may go home
black and blue and really feel your shift the
next day. No matter how tired you are or how
tedious some of the jobs may seem, it will all
be worthwhile when you see your first foal
progress from lying in a coma on a fleece lined
mattress, to running and bucking at the side of
its dam as it plays outside for the first time.
Who are foal sitters? They come from all
walks of life. Many are college students who
want to find out what veterinary medicine is
all about. Others are nurses from human hos-
pitals, looking for a change of pace. Still others
are horsewomen and horsemen from the com-
munity who just feel good helping these little
patients.
If you are interested, email us at foalsit-
ters@vet.upenn.edu or call the foal sitter hot
line at 610-444-5800, ext. 2445. You must
register by December 1 to be able to help
during the 2003 foaling season.
Foal Sitting
